Maternal insulin therapy increases fetal endothelial progenitor cells during diabetic pregnancy

Diabetes Care

Volumn 31, Issue 4, 2008, Pages 808-810

  Fadini, Gian Paolo ^a,b   Baesso, Ilenia ^a   Agostini, Carlo ^a   Cuccato, Emily ^a   Nardelli, Giovanni Battista ^a   Lapolla, Annunziata ^a   Avogaro, Angelo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; FETUS CIRCULATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN TREATMENT; MATERNAL CARE; PREGNANCY DIABETES MELLITUS; PREVALENCE; STEM CELL; BIRTH WEIGHT; CYTOLOGY; DRUG EFFECT; FETUS; FETUS BLOOD; HYPERGLYCEMIA; METABOLISM; NEWBORN; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT; VASCULAR ENDOTHELIUM;

BIRTH WEIGHT; DIABETES, GESTATIONAL; ENDOTHELIUM, VASCULAR; FEMALE; FETAL BLOOD; FETUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; STEM CELLS;

EID: 48649097304     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-1996     Document Type: Article

References (13)

1. Fadini GP, Agostini C, Sartore S, Avogaro A: Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 194:46-54, 2007
2. Fadini GP, Sartore S, Agostini C, Avogaro A: Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 30:1305-1313, 2007
3. Matsubara K, Abe E, Matsubara Y, Kameda K, Ito M: Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol 56:79-85, 2006
4. Buemi M, Allegra A, D'Anna R, Coppolino G, Crasci E, Giordano D, Loddo S, Cucinotta M, Musolino C, Teti D: Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. Am J Obstet Gynecol 196:68.e1-68.e6, 2007
5. Krankel N, Adams V, Linke A, Gielen S, Erbs S, Lenk K, Schuler G, Hambrecht R: Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb Vasc Biol 25:698-703, 2005
6. Kwon JY, Maeng YS, Kwon YG, Kim YH, Kang MH, Park YW: Decreased endothelial progenitor cells in umbilical cord blood in severe preeclampsia. Gynecol Obstet Invest 64:103-108, 2007
7. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 27 (Suppl. 1):S15-S35, 2004
8. Fadini GP, de Kreutzenberg SV, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A: Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J27:2247-2255, 2006
9. Fadini GP, Coracina A, Baesso I, Agostini C, Tiengo A, Avogaro A, de Kreutzenberg SV: Peripheral blood CD34 + KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke 37:2277-2282, 2006
10. Fadini GP, Avogaro A, Agostini C: Critical assessment of putative endothelial progenitor phenotypes. Exp Hematol 35: 1479-1480, 2007
11. Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I, Cabrelle A, Agostini C, Avogaro A: Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 49:3075-3084, 2006
12. Humpert PM, Neuwirth R, Battista MJ, Voronko O, von Eynatten M, Konrade I, Rudofsky G Jr, Wendt T, Hamann A, Morcos M, Nawroth PP, Bierhaus A: SDF-1 genotype influences insulin-dependent mobilization of adult progenitor cells in type 2 diabetes. Diabetes Care 28:934-936, 2005
13. Huu SN, Oster M, Uzan S, Chareyre F, Aractingi S, Khosrotehrani K: Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells. Proc Natl Acad Sci USA 104:1871-1876, 2007